666

HANDA PHARMACEUTICALS INC

No trades
See on Supercharts
Market capitalization
‪7.96 B‬TWD
‪726.89 M‬TWD
‪1.11 B‬TWD
‪121.89 M‬
Beta (1Y)
1.20

About HANDA PHARMACEUTICALS INC


CEO
Fang Yue Liu
Headquarters
Tainan
Founded
2005
ISIN
TW0006620008
FIGI
BBG00FM0S705
Handa Pharmaceuticals, Inc. engages in the research, development, design, and sale of pharmaceutical business. It focuses on the development of niche drug. It offers 505(b)2 new drugs, high-tech generic drugs and other biotechnology services. The company was founded by Yu Ling Fang on May 8, 2014 and is headquartered in Tainan, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6620 is 54.6 TWD — it has decreased by −2.48% in the past 24 hours. Watch HANDA PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange HANDA PHARMACEUTICALS INC stocks are traded under the ticker 6620.
6620 stock has fallen by −4.84% compared to the previous week, the month change is a −5.82% fall, over the last year HANDA PHARMACEUTICALS INC has showed a −67.69% decrease.
6620 reached its all-time high on Feb 24, 2023 with the price of 217.6 TWD, and its all-time low was 15.0 TWD and was reached on Mar 30, 2020. View more price dynamics on 6620 chart.
See other stocks reaching their highest and lowest prices.
6620 stock is 6.42% volatile and has beta coefficient of 1.20. Track HANDA PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is HANDA PHARMACEUTICALS INC there?
Today HANDA PHARMACEUTICALS INC has the market capitalization of ‪7.96 B‬, it has decreased by −4.47% over the last week.
Yes, you can track HANDA PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
6620 net income for the last quarter is ‪102.37 M‬ TWD, while the quarter before that showed ‪117.09 M‬ TWD of net income which accounts for −12.57% change. Track more HANDA PHARMACEUTICALS INC financial stats to get the full picture.
Yes, 6620 dividends are paid annually. The last dividend per share was 1.00 TWD. As of today, Dividend Yield (TTM)% is 1.77%. Tracking HANDA PHARMACEUTICALS INC dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANDA PHARMACEUTICALS INC EBITDA is ‪535.64 M‬ TWD, and current EBITDA margin is 63.80%. See more stats in HANDA PHARMACEUTICALS INC financial statements.
Like other stocks, 6620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANDA PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANDA PHARMACEUTICALS INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANDA PHARMACEUTICALS INC stock shows the sell signal. See more of HANDA PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.